학술논문
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2
Document Type
Article
Author
Source
In: Annals of Internal Medicine . (Annals of Internal Medicine, 1 March 2024, 177(3):343-352)
Subject
Language
English
ISSN
15393704
00034819
00034819